References
- Aroujo LM, Thomazine JA, Lopez RFV. (2010). Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm 75:48–55
- Biel MA. (2010). Photodynamic therapy in head and neck cancer. Curr Oncol Reports 4:87–96
- Bose S, Michniak-Kohn B. (2013). Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur J Pharm Sci 12:1–43
- Cirri M, Bragagni M, Mennini N, Mura P. (2012). Development of a new delivery system consisting in “drug – in cyclodextrin in nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm 80:46–53
- Curic ND, Fahr A. (2012). Liposomes in topical photodynamic therapy. Expert Opin Drug Deliv 9:1015–32
- Dougherty TJ, Gomer CJ, Henderson BW, et al. (1998). Photodynamic therapy. J Natl Cancer Inst 90:889–905
- Enk CD, Levi A. (2012). Low-irradiance red LED traffic lamps as light source in PDT for actinic keratoses. Photodermatol Photoimmunol Photomed 28:332–4
- Fang YP, Tsai YH, Wu PC, Huang YB. (2008). Comparison of 5-aminolevulinicacid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm 365 144–52
- Fazil M, Shadab M, Haque S, et al. (2012). Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 47:6–15
- Ferdous R, Anisuzzaman SM, Paul AK, et al. (2012). In vitro release kinetic study of gliclazide from methocel k 100 mcr and methocel k100lvcr matrix tablets. Int J PharmTech Res 4:883–8
- Gasco MR. (1993). Method of producing solid lipid microspheres having narrow size distribution. US Patent 5250:236
- Hopper C. (2000). Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol 1:212–19
- Kubler AC, Haase T, Staff C. (1999). Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 25:60–8
- Lear JT, Harvey I, de Berker D, et al. (1998). Basal cell carcinoma. J R Soc Med 91:585–8
- Lee C, Qiao X, Goeger DK, Anderson KE. (2004). Fluorometric measurement of 5-aminolevulinic acid in serum. Clin Chim Acta 347:183–8
- Leiter U, Garbe C. (2008). Epidemiology of melanoma and nonmelanoma skin cancer – the role of sunlight. Adv Exp Med Biol 624:89–103
- Muchow M, Maincent P, Muller RH. (2008). Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm 34:1394–405
- Muller RH, Mader K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50:161–77
- Oliveira FM, Santana DCA, Taveira SF, et al. (2010). Development of nitrosyl ruthenium complex loaded lipid carriers for topical administration: improvement in skin stability and nitric oxide release by visible light irradiation. J Pharm Biomed Anal 53:843–51
- Pierre MB, Ricci E, Jr, Tedesco AC, Bentley MV. (2006). Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res 23:360–6
- Rosa FSD, Tedesco AC, Lopez RFV, et al. (2003). In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Rel 89:261–9
- Song CK, Balakrishnan P, Shim CK, et al. (2012). A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces 92:299–304
- Souza LG, Silva EJ, Martins ALL, Mota MF. (2011). Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release. Eur J Pharm Biopharm 79:189–96
- Tan Q, Liu W, Guo C, Zhai G. (2011). Preparation and evaluation of quercetin-loaded lecithin chitosan nanoparticles for topical delivery. Int J Nanomed 6:1621–30